Table 2.

Target gene/GAPDH-mRNA abundance.

Target gene	Control	EAE (2−ΔCt; % of control; statistical difference)
↑ Entpd1	0.01984 ± 0.00208	0.03253 ± 0.00813 (164.0 ± 11.3%, t = 2.52, df = 8, p = 0.0356)
↓ Entpd2	0.03414 ± 0.00107	0.02169 ± 0.0038 (63.5 ± 23.0%, t = 4.87, df = 8, p = 0.0012)
↑ Nt5e	0.01166 ± 0.00200	0.01754 ± 0.00052* (150.4 ± 24.6%, t = 13.35, df = 8, p < 0.0001)
Ada	0.00237 ± 0.00032	0.00212 ± 0.00057 (t = 0.95, df = 8, p = 0.3571)
Ent1	0.00225 ± 0.00039	0.00225 ± 0.00060 (t = 0.13, df = 8, p = 0.9896)
Ent2	0.00367 ± 0.00032	0.00259 ± 0.00048 (t = 0.13, df = 8, p = 0.9896)
↑ Adora1	0.01563 ± 0.00065	0.01986 ± 0.00513* (127.1 ± 9.6%, t = 2.63, df = 8, p = 0.0206)
Adora 2a	0.00374 ± 0.00019	0.00333 ± 0.00078 (t = 0.92, df = 8, p = 0.3832)
Adora2b	0.00522 ± 0.00068	0.00412 ± 0.00071 (t = 1.90, df = 8, p = 0.0937)
↑ Adora3	0.00900 ± 0.00128	0.02558 ± 0.0038* (284.2 ± 72.33%, t = 6.375, df = 8, p = 0.0002)
P2xr2	0.00037 ± 0.00014	0.00030 ± 0.00061 (t = 1.61, df = 8, p = 0.1298)
↑ P2xr4	0.02456 ± 0.00433	0.04073 ± 0.00829* (165.8 ± 12.3, t = 5.59, df = 8, p < 0.0001)
P2xr7	0.00373 ± 0.00060	0.00375 ± 0.00107 (t = 0.40, df = 8, p = 0.6929)
P2ry1	0.00535 ± 0.00062	0.00484 ± 0.00096 (t = 2.04, df = 8, p = 0.059)
↑ P2ry12	0.00869 ± 0.00162	0.01210 ± 0.00159* (139 ± 1.9%, t = 4.24, df = 8, p = 0.0007)
↑ Tnfa	0.00055 ± 0.00005	0.00258 ± 0.00147* (469.1 ± 185.0%, t = 3.78, df = 8, p = 0.0054)
↑Il1b	0.00053 ± 0.00015	0.00439 ± 0.00236* (828.3 ± 298.4%, t = 3.19, df = 8, p = 0.0127)
↑ Il6	0.00004 ± 0.00010	0.00024 ± 0.00005* (600.0 ± 35.7%, t = 3.46, df = 8, p = 0.0085)
↑Lcn2	0.00007 ± 0.00002	0.00117 ± 0.00050* (1,671 ± 140.4%, t = 3.40, df = 8, p = 0.0093)
↑C3	0.02241 ± 0.00369	0.12017 ± 0.02740* (536.2 ± 180.5%, t = 5.50, df = 8, p = 0.0006)